Status:
COMPLETED
Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Takeda
Conditions:
Type 2 Diabetes
Obesity
Eligibility:
All Genders
21-65 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure th...
Detailed Description
The three lifestyle interventions were usual care (1 visit), standard care (4 total visits) and intensive care (10 total visits)
Eligibility Criteria
Inclusion
- type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater
Exclusion
- insulin treated
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00737347
Start Date
September 1 2003
End Date
April 1 2008
Last Update
August 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital Wellness Institute
Chicago, Illinois, United States, 60611